Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Jul 22 424B3 Prospectus supplement
- 29 Jul 22 EFFECT Notice of effectiveness
-
26 Jul 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Jun 22 S-4 Registration of securities issued in business combination transactions
LSTA similar filings
- 26 Jul 22 Registration of securities issued in business combination transactions (amended)
- 15 Jun 22 Registration of securities issued in business combination transactions
- 2 Sep 11 Registration of securities issued in business combination transactions
- 30 Nov 10 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
We hereby consent to the use in this Prospectus constituting a part of this Registration Statement on Form S-4, Amendment No. 1, of our report dated May 20, 2022 relating to the consolidated financial statements of Cend Therapeutics, Inc., which is contained in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
San Francisco, California
July 26, 2022